Biocon Biologics Partners with Sandoz Australia for Trastuzumab and Bevacizumab
The agreement is effective from January 1, 2024 and commercialisation commenced on February 1, 2024
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.